Back to search

Article

Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in glioma

2023-06-14

Abstract excerpt

<h4>Purpose: </h4> The advent of immune checkpoint blockade (ICB) therapies this year has changed the way glioblastoma (GBM) is treated. Meanwhile, some patients with strong PD-L1 expression remain immune checkpoint resistant. To better understand the molecular processes that influence the immune environment, there is an urgent need to characterize the immunosuppressive tumor microenvironment and identify biomarke...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
67f6ac0e-fbae-5387-a3ff-8b57cd5a0ed5
DOI
10.21203/rs.3.rs-3047999/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in gliomaDOI 10.21203/rs.3.rs-3047999/v1
Select a neighboring publication to make it the new centre.